3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
aldesleukin
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Brachytherapy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
talazoparib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
belzutifan
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Paclitaxel
1
Observation
1
Nivolumab
1
Methods
1
Interviews as Topic
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
tipifarnib
×
1 year
×
Clear all
No trials found.